Director, Massachusetts Alzheimer's Disease Research Center & John B. Penney Jr. Professor of Neurology, Harvard Medical School
Alzheimer's Unit Director, MassGeneral Institute for Neurodegenerative Disease
Dr. Hyman directs the Alzheimer’s unit at MIND (Massachusetts Institute for Neurodegenerative Disease), with the goal of understanding the neuropathophysiologic and genetic factors that underlie dementia. The take-off point for Dr. Hyman’s research program involves understanding the neural system failure that underlies cognitive loss in Alzheimer’s, and an appreciation of how genetics impacts pathophysiology. His laboratory also uses transgenic mouse models of Alzheimer’s disease and in vitro systems to examine the roles of presenilin mutations and receptors in neuronal function and on Alzheimer’s related processes.
A recent initiative in Dr. Hyman’s laboratory has been the development of in vivo imaging with 2-photon confocal microscopy. This provides the ability to view neurons in the intact, functioning brain in mice and track the pathological changes that occur during disease processes. His lab has shown that plaques can be reversed by therapeutic application of antibodies.
Dr. Hyman is statewide chair of the Massachusetts Alzheimer’s Association Memory Walk.